Virupaksha Organics Profile
Key Indicators
- Authorised Capital ₹ 45.00 Cr
- Paid Up Capital ₹ 41.02 Cr
- Company Age 27 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 304.83 Cr
- Satisfied Charges ₹ 80.12 Cr
- Revenue Growth 36.33%
- Profit Growth 150.16%
- Ebitda 115.36%
- Net Worth 25.06%
- Total Assets 19.21%
About Virupaksha Organics
Virupaksha Organics Limited (VOL) is a leading Public Limited Indian Non-Government Company incorporated in India on 03 November 1997 and has a history of 27 years and two months. Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Drk Chemicals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 45.00 Cr and a paid-up capital of Rs 41.02 Cr.
The company currently has active open charges totaling ₹304.83 Cr. The company has closed loans amounting to ₹80.12 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Virupaksha Organics Limited India are Vikas Kurada as COMPANY SECRETARY and Prasad Battinapatla as Cfo. Chandra Gangavaram, Balasubba Mamilla, Vedavathi Gangavaram, and Three other members serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24110TG1997PLC028281
- Company No.
028281
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
03 Nov 1997
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Virupaksha Organics Limited offer?
Virupaksha Organics Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Inflammatory and Immunosuppressant API, Hormones and Steroid API, Industrial Chemicals & Supplies, Aldehydes, Sexual Wellness Products, Fertility Enhancer, Common Disease Medicines, Steroid, Antihistamines.
Who are the key members and board of directors at Virupaksha Organics?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vikas Kurada | Company Secretary | 17-Jun-2023 | Current |
| Prasad Battinapatla | CFO | 13-Jun-2024 | Current |
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandra Gangavaram  | Director | 21-Jul-2003 | Current |
| Balasubba Mamilla | Whole-Time Director | 03-Nov-1997 | Current |
| Vedavathi Gangavaram | Director | 04-Jan-2012 | Current |
| Janardhana Yeddula | Director | 03-Aug-2022 | Current |
| Chandrasekhar Gangavaram | Whole-Time Director | 04-Jan-2012 | Current |
| Shruti Gupta | Director | 03-Mar-2021 | Current |
Financial Performance of Virupaksha Organics.
Virupaksha Organics Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 36.33% increase. The company also saw a substantial improvement in profitability, with a 150.16% increase in profit. The company's net worth Soared by an impressive increase of 25.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Virupaksha Organics?
In 2023, Virupaksha Organics had a promoter holding of 74.48% and a public holding of 25.52%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Viruj Pharmaceuticals Private LimitedBalasubba Mamilla is a mutual person
V Indaf Overseas Private LimitedVedavathi Gangavaram is a mutual person
_LIMITED.webp)
Sri Avantika Contractors (I) LimitedShruti Gupta is a mutual person
Virupaksha Minerals LlpChandra Gangavaram and Vedavathi Gangavaram are mutual person
- Virupaksha Laboratories Private Limited
Chandra Gangavaram, Balasubba Mamilla and 1 more are mutual person
- Virupaksha Securities Private Limited
Chandra Gangavaram and Vedavathi Gangavaram are mutual person
Charges (Loans)
₹304.83 Cr
₹80.12 Cr
Charges Breakdown by Lending Institutions
- Others : 136.35 Cr
- State Bank Of India : 96.31 Cr
- Axis Bank Limited : 71.86 Cr
- Hdfc Bank Limited : 0.32 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Mar 2024 | Axis Bank Limited | ₹5.25 M | Open |
| 09 Feb 2024 | State Bank Of India | ₹1.15 Cr | Open |
| 04 Jan 2024 | Axis Bank Limited | ₹3.20 M | Open |
| 31 Dec 2023 | Axis Bank Limited | ₹3.30 M | Open |
| 25 Jan 2023 | Axis Bank Limited | ₹4.20 M | Open |
How Many Employees Work at Virupaksha Organics?
Virupaksha Organics has a workforce of 708 employees as of Sep 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Virupaksha Organics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Virupaksha Organics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
